BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 29602763)

  • 1. Advances in the treatment of extranodal NK/T-cell lymphoma, nasal type.
    Yamaguchi M; Suzuki R; Oguchi M
    Blood; 2018 Jun; 131(23):2528-2540. PubMed ID: 29602763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus-associated natural killer/T-cell lymphomas.
    Asano N; Kato S; Nakamura S
    Best Pract Res Clin Haematol; 2013 Mar; 26(1):15-21. PubMed ID: 23768637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and future management of NK/T-cell lymphoma based on clinical trials.
    Yamaguchi M
    Int J Hematol; 2012 Nov; 96(5):562-71. PubMed ID: 23073619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current treatment approaches for NK/T-cell lymphoma.
    Yamaguchi M; Miyazaki K
    J Clin Exp Hematop; 2017 Dec; 57(3):98-108. PubMed ID: 28679966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extranodal natural killer/T cell lymphoma: we should and we can do more.
    Ying Z; Zhu J
    Chin Clin Oncol; 2015 Mar; 4(1):12. PubMed ID: 25841719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Features and Current Optimal Management of Natural Killer/T-Cell Lymphoma.
    Makita S; Tobinai K
    Hematol Oncol Clin North Am; 2017 Apr; 31(2):239-253. PubMed ID: 28340876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NK/T Cell Lymphoma: Updates in Therapy.
    Suzuki R
    Curr Hematol Malig Rep; 2018 Feb; 13(1):7-12. PubMed ID: 29368155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and management of extranodal NK/T cell lymphoma nasal type.
    Tse E; Kwong YL
    Expert Rev Hematol; 2016 Sep; 9(9):861-71. PubMed ID: 27347812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Incidence and treatment of extranodal natural killer/T-cell lymphoma nasal type. Hungarian experiences].
    Bakos A; Szomor Á; Schneider T; Miltényi Z; Marton I; Borbényi Z; Pammer J; Krenács L; Bagdi E; Piukovics K
    Orv Hetil; 2017 Oct; 158(41):1635-1641. PubMed ID: 29025287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis and treatment of extranodal natural killer/T-cell lymphoma.
    Suzuki R
    Semin Hematol; 2014 Jan; 51(1):42-51. PubMed ID: 24468315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of extranodal natural killer/t-cell lymphoma, nasal type.
    Chaudhary RK; Bhatt VR; Vose JM
    Clin Lymphoma Myeloma Leuk; 2015 May; 15(5):245-52. PubMed ID: 25659751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent Chemoradiation Therapy Followed by Consolidation Chemotherapy for Localized Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type.
    Oh D; Ahn YC; Kim SJ; Kim WS; Ko YH
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):677-83. PubMed ID: 26461010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of advanced NK/T-cell lymphoma.
    Tse E; Kwong YL
    Curr Hematol Malig Rep; 2014 Sep; 9(3):233-42. PubMed ID: 24924658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How we treat NK/T-cell lymphomas.
    Tse E; Zhao WL; Xiong J; Kwong YL
    J Hematol Oncol; 2022 Jun; 15(1):74. PubMed ID: 35659326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Extranodal NK/T-cell lymphoma].
    Suzuki R
    Nihon Rinsho; 2014 Mar; 72(3):524-30. PubMed ID: 24724414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the management and monitoring of extranodal NK/T-cell lymphoma, nasal type.
    Liang R
    Br J Haematol; 2009 Oct; 147(1):13-21. PubMed ID: 19604234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extranodal NK/T-cell lymphoma: Updates in biology and management strategies.
    Yamaguchi M; Oguchi M; Suzuki R
    Best Pract Res Clin Haematol; 2018 Sep; 31(3):315-321. PubMed ID: 30213402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and management of natural killer-cell malignancies.
    Ishida F; Kwong YL
    Expert Rev Hematol; 2010 Oct; 3(5):593-602. PubMed ID: 21083476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pralatrexate as a bridge to allogeneic hematopoietic stem cell transplantation in a patient with advanced-stage extranodal nasal-type natural killer/T cell lymphoma refractory to first-line chemotherapy: a case report.
    Liu YC; Lin TA; Wang HY; Ko PS; Liu CJ; Hsiao LT; Chien SH; Gau JP
    J Med Case Rep; 2020 Mar; 14(1):43. PubMed ID: 32183896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnosis and management of NK/T-cell lymphomas.
    Tse E; Kwong YL
    J Hematol Oncol; 2017 Apr; 10(1):85. PubMed ID: 28410601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.